DSpace JSPUI
DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets
Learn More
Browsing by Author Hughes, Michael D.
Showing results 1 to 3 of 3
| Issue Date | Title | Author(s) |
| 2024-05-13 | Effectiveness of Double-Dose Dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV From 6 Countries | Shah, N. Sarita; Kityo, Cissy; Hughes, Michael D.; McCarth, Caitlyn; Wallis, Carole L.; Hosseinipour, Mina C.; Langat, Deborah; Nyirenda, Mulinda; Rassoo, Mohammed; Dawson, Rodney; Joseph, Yvetot; Some, Fatma; Mngqibisa, Rosie; Mukwekwerere, Pamela Grace; Woolley, Elizabeth; Godfrey, Catherine; Manabe, Yukari C.; Mellors, John W.; Flexner, Charles; Maartens, Gary |
| 2022-06 | Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial | Avihingsanon, Anchalee; Hughes, Michael D.; Salata, Robert; Godfrey, Catherine; McCarthy, Caitlyn; Mugyenyi, Peter |
| 2022 | Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial | Avihingsanon1, Anchalee; Hughes, Michael D.; Salata, Robert; Godfrey, Catherine; McCarthy, Caitlyn |
